Indian pharma stocks soared today following the announcement that former U.S. President Donald Trump would pause potential pharmaceutical tariffs if re-elected, aiming to avoid disruption to critical medicine imports. The move sent ripples across the global equity markets, but it was Indian pharma players who led the charge. Laurus Labs, Granules India, and Cipla witnessed […]
In a significant shift of monetary policy stance, the Reserve Bank of India (RBI) has subtly pivoted from being a relentless inflation hawk to becoming a cautious growth enabler. This transition is being closely watched by market participants, particularly those involved in index futures trading strategies India and actively seeking the best trading platform for […]
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Standard Disclaimer: Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
2025 © Finversify. All rights reserved.